592 Biomaterials for Immunological Applications II: Cancer Immunotherapy and Autoimmune Disease Treatments


Description:
This session will highlight recent advances in the immunological applications of biomaterials. Submissions covering innate and adaptive immune strategies are welcome. Relevant topics include but are not limited to novel biomaterial interactions with the immune system, biomaterials for vaccines or antimicrobial applications, immunosuppressive strategies, controlled release of immunomodulatory agents (including antigens, cytokines, chemokines, immunosuppressive agents, etc.), immune cell activation or differentiation strategies, biomimetic strategies, and detection strategies for varying immunological functions. Topics in cancer immunotherapy, autoimmune therapy, and tolerance induction are also desirable. Graduate Students: By applying to this session you may be eligible for the Biomaterials Graduate Student Award Session established to honor the best graduate student submissions through recognition and cash awards. See the session titled “Biomaterials: Graduate Student Award Session” for details.

Sponsor:
Biomaterials
Co-Sponsor(s):
Engineering Fundamentals in Life Science (15D)


Chair:
Bret Ulery
University of Missouri
Bioengineering
Columbia, MO
Email: uleryb@missouri.edu

Co-chairs:
R. Michael Gower
Assistant Professor
University of South Carolina
303 E Superior St

SC
60208
Email: gowerrm@mailbox.sc.edu

Peipei Zhang
Postdoctoral Researcher
University of Maryland
Fischell Department of Bioengineering
2525 Pottsdamer St. A131
College Park, MD
32310
Fax Number: 850-410-6150
Email: pzhang14@umd.edu


Papers:
592a
Pegylation of Model Drug Carriers Enhances Uptake By Primary Human Neutrophils
William Kelley, University of Michigan; Catherine A Fromen, University of Michigan; Omolola Eniola-Adefeso, University of Michigan
592b
“Smart” Nanoparticles for Immunotherapeutic Targeting of the Sting Pathway
Daniel Shae, Vanderbilt University; Denise Buenrostro, Vanderbilt University; Alyssa Merkel, Vanderbilt University; Sema Sevimli, Vanderbilt University; Julie A. Sterling, Vanderbilt University Medical Center; John Wilson, Vanderbilt University
592c
Biomaterial Nanoparticles Redistribute Therapeutic Antibodies to Lymph Node-Resident Cells to Enhance Cancer Immunotherapy Via Checkpoint Inhibition
David Francis, Georgia Institute of Technology; Alex Schudel, Georgia Institute of Technology; Nathan A. Rohner, Georgia Institute of Technology; Susan N. Thomas, Georgia Institute of Technology
592d
Engineering Nanoparticle Artificial Antigen Presenting Cells Based on T Cell Biology Improves T Cell Enrichment and Activation for Cancer Immunotherapy
John Hickey, Johns Hopkins University; Fernando Vicente, Biomedical Engineering; Hai-Quan Mao, Johns Hopkins University; Jonathan Schneck, Johns Hopkins University
592e
Biomaterial Scaffolds for Combined Focal Ablation and Immunotherapy to Target Disseminated Cancer
Francisco Pelaez, University of Minnesota; Stephen O'Flanagan, University of Minnesota; Qi Shao, University of Minnesota; Brandon Burbach, University of Minnesota; Tiffany Lam, University of Minnesota; John C. Bischof, University of Minnesota; Yoji Shimizu, University of Minnesota; Samira M. Azarin, University of Minnesota
592f
Modulating the Immune Environment within Adipose Tissue with Polymer Scaffolds
Kendall Murphy, University of South Carolina; Michael Gower, University of South Carolina
592g
Multi-Factor Microparticle Formulation for Local Induction of Regulatory Lymphocytes and Treatment of Periodontal Disease
Ashlee Greene, University of Pittsburgh; Sayuri Yoshizawa, University of Pittsburgh; Michelle Ratay, University of Pittsburgh; Charles Sfeir, University of Pittsburgh; Steven R. Little, University of Pittsburgh
592h
Multivalent Soluble Antigen Arrays Target Antigen Presenting B Cells and Dampen Antigen-Specific Signaling to Promote Therapeutic Efficacy in Multiple Sclerosis
Brittany Hartwell, Massachusetts Institute of Technology
Abstract Submissions Closed
See more of this Group/Topical: Materials Engineering and Sciences Division
<< Previous Session | Next Session >>